VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NVNO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NVNOenVVeno Medical Corporation
$11.02$7M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNVNOQuarterly Financials

enVVeno Medical Corporation (NVNO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

enVVeno Medical Corporation (NVNO) quarterly income statement — complete revenue, gross profit & net income history

NVNO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold0117K120K130K122K122K129K136K141K134K138K138K136K130K133K133K129K121.59K120.14K107.5K
COGS % of Revenue--------------------
Gross Profit0-117K-120K-130K-122K-122K-129K-136K-141K-134K-138K-138K-136K-130K-133K-133K-129K-121.59K-120.14K-107.5K
Gross Margin %--------------------
Gross Profit Growth %100%4.1%6.98%4.41%13.48%8.96%6.52%1.45%-3.68%-3.08%-3.76%-3.76%-5.43%-6.92%-10.71%-23.72%-24.42%-26.68%-21.92%-3.97%
Operating Expenses4.06M3.9M4.76M6.92M4.83M6.58M6.04M5.32M5.36M6.14M5.21M6.68M6.66M6.33M6.02M6.85M5.21M8.87M2.59M2.28M
OpEx % of Revenue--------------------
Selling, General & Admin1.95M2.06M2.18M4.03M2.27M3.06M3.18M2.49M2.31M3.16M2.41M2.46M3.07M3.53M3.53M3.78M3.65M7.09M1.36M1.19M
SG&A % of Revenue--------------------
Research & Development2.11M1.95M2.58M2.89M2.56M3.51M2.86M2.83M3.05M2.98M2.8M4.21M3.6M2.8M2.49M3.07M1.55M1.78M1.22M1.09M
R&D % of Revenue--------------------
Other Operating Expenses0-117K000000000000000000
Operating Income-4.06M-4.01M-4.88M-7.05M-4.95M-6.7M-6.17M-5.45M-5.5M-6.28M-5.35M-6.81M-6.8M-6.46M-6.15M-6.99M-5.33M-8.99M-2.71M-2.39M
Operating Margin %--------------------
Operating Income Growth %18.01%40.1%20.86%-29.24%9.98%-6.71%-15.35%19.96%19.04%2.82%13.04%2.46%-27.4%28.16%-127.27%-192.86%-89.98%-116.24%-40.8%-54.31%
EBITDA-4.06M-3.9M-4.76M-6.92M-4.83M-6.58M-6.04M-5.32M-5.36M-6.14M-5.21M-6.68M-6.66M-6.33M-6.02M-6.85M-5.21M-8.87M-2.59M-2.28M
EBITDA Margin %--------------------
EBITDA Growth %15.94%40.76%21.16%-30.11%9.88%-7.05%-15.93%20.34%19.5%2.94%13.41%2.58%-27.95%28.64%-132.68%-200.84%-92.49%-118.36%-41.82%-57.92%
D&A (Non-Cash Add-back)0117K120K130K122K122K129K136K141K134K138K138K136K130K133K133K129K121.59K120.14K107.5K
EBIT0-4.01M-4.54M-6.69M-4.5M-6.23M-5.64M-4.96M-4.99M-5.65M-5M-6.47M-6.39M-6.18M-6.1M-7.06M-5.33M-8.99M-2.39M-2.38M
Net Interest Income0103K175K195K219K163K94K73K59K52K44K39K45K44K75K37K5K4.53K4.52K6.7K
Interest Income22K103K175K195K219K163K94K73K59K52K44K39K45K44K75K37K5K4.53K4.52K6.7K
Interest Expense00000000000000000000
Other Income/Expense213K277K344K355K451K470K528K498K511K629K348K340K405K280K54K-76K5K4.53K317.22K8K
Pretax Income-3.85M-3.74M-4.54M-6.69M-4.5M-6.23M-5.64M-4.96M-4.99M-5.65M-5M-6.47M-6.39M-6.18M-6.1M-7.06M-5.33M-8.99M-2.39M-2.38M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-3.85M-3.74M-4.54M-6.69M-4.5M-6.23M-5.64M-4.96M-4.99M-5.65M-5M-6.47M-6.39M-6.18M-6.1M-7.06M-5.33M-8.99M-2.39M-2.38M
Net Margin %--------------------
Net Income Growth %14.52%40.02%19.55%-35.07%9.8%-10.27%-12.82%23.45%21.9%8.59%17.98%8.33%-19.93%31.24%-155.18%-196.99%-92.22%-105.48%-20.99%-46.16%
Net Income (Continuing)-3.85M-3.74M-4.54M-6.69M-4.5M-6.23M-5.64M-4.96M-4.99M-5.65M-5M-6.47M-6.39M-6.18M-6.1M-7.06M-5.33M-8.99M-2.39M-2.38M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-5.89-5.91-281.75-404.25-269.50-379.75-428.75-379.75-379.75-514.50-551.25-710.50-698.25-796.25-661.50-771.75-575.75-980.00-318.50-343.00
EPS Growth %97.81%98.44%34.29%-6.45%29.03%26.19%22.22%46.55%45.61%35.38%16.67%7.94%-21.28%18.75%-107.69%-125%2.08%61.35%81.16%85.19%
EPS (Basic)-5.89-5.91-281.75-404.25-269.50-379.75-428.75-379.75-379.75-514.50-551.25-710.50-698.25-796.25-661.50-771.75-575.75-980.00-318.50-343.00
Diluted Shares Outstanding654K589K16.45K16.61K16.61K16.64K13.12K13.12K13.11K10.87K9.17K9.17K9.17K7.73K9.17K9.17K9.17K9.14K7.49K6.95K
Basic Shares Outstanding654K589K16.45K16.61K16.61K16.64K13.12K13.12K13.11K10.87K9.17K9.17K9.17K7.73K9.17K9.17K9.17K9.14K7.49K6.95K
Dividend Payout Ratio--------------------